Craig Millian
Chief Executive Officer at HLS THERAPEUTICS INC.
Net worth: 64 650 $ as of 30/04/2024
Craig Millian active positions
Companies | Position | Start | End |
---|---|---|---|
HLS THERAPEUTICS INC. | Director/Board Member | 01/05/2023 | - |
Chief Executive Officer | 01/05/2023 | - |
Career history of Craig Millian
Former positions of Craig Millian
Companies | Position | Start | End |
---|---|---|---|
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Chief Operating Officer | 24/09/2021 | 14/04/2023 |
Corporate Officer/Principal | 28/02/2019 | 24/09/2021 | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 14/06/2012 | 01/12/2018 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - | - |
Training of Craig Millian
University of Pennsylvania | Undergraduate Degree |
New York University | Masters Business Admin |
Statistics
International
United States | 6 |
Canada | 2 |
Operational
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
HLS THERAPEUTICS INC. | Health Technology |
Private companies | 1 |
---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Stock Market
- Insiders
- Craig Millian
- Experience